Anorexia: Treatment options for patients with advanced cancer

Aminah Jatoi, Phuong L. Nguyen

Research output: Contribution to journalReview articlepeer-review


In patients with advanced cancer, anorexia, or loss of appetite, is prevalent, distressing, and predictive of a poor prognosis. Patients with cancer who are receiving antineoplastic treatment experience this symptom, as do patients with cancer who are no longer receiving such therapy. Yet palliative options remain limited. The two most frequently used palliative measures employ progestational agents and corticosteroids. Both classes of agents provide only modest clinical benefits. Recent studies suggest promising results with melatonin, blockade of tumor necrosis factor-α, necrosis factor-κ B decoys, adenosine triphosphate, antiemetics, and anti-inflammatory agents. These agents appear promising, but further clinical research is needed before they can be prescribed outside clinical trial settings.

Original languageEnglish (US)
Pages (from-to)269-275
Number of pages7
JournalAmerican Journal of Cancer
Issue number4
StatePublished - 2002

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Anorexia: Treatment options for patients with advanced cancer'. Together they form a unique fingerprint.

Cite this